A rare case of pediatric recurrent rhabdomyolysis with compound heterogenous variants in the LPIN1
Open Access
- 14 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pediatrics
- Vol. 20 (1), 1-6
- https://doi.org/10.1186/s12887-020-02134-5
Abstract
Lipin-1, encoded by LPIN1 gene, serves as an enzyme and a transcriptional co-regulator to regulate lipid metabolism and mitochondrial respiratory chain. Autosomal recessive mutations in LPIN1 were recognized as one of the most common causes of pediatric recurrent rhabdomyolysis in western countries. However, to date, there were only a few cases reported in Asian group. This study aims to report the first pediatric case of recurrent rhabdomyolysis with a novel LPIN1 mutation in China mainland in order to raise the awareness of both pediatricians and patients. Here we report a Chinese pediatric case of recurrent rhabdomyolysis with compound heterozygous variants (p.Arg388* and p.Arg810Cys) in the LPIN1 gene. The c.2428C > T was a novel missense variant involved Arg-to-Cys substitution at position 810 (p.Arg810Cys), located in the highly conserved region which predicted to be damaging by multiple algorithms. The patient manifested as cola-colored urine, muscle weakness and tenderness, as well as acute kidney injury with peak blood creatine kinase level 109,570 U/l in 19-month old. In his second episode of 9 years old, the symtoms were relatively milder with peak creatine kinase level 50,948 U/l. He enjoyed quite normal life between the bouts but slightly elevation of serum creatine kinase level during the fever or long-term exercises. Prolonged weight training combined with calorie deprivation were speculated to be the triggers of his illness. Prompt symptomatic therapy including fluid therapy and nutritional support was given and the patient recovered soon. LPIN1-related rhabdomyolysis is still quite new to physicians due to its seemly low-incidence especially in Asian countries. In the future, more active genetic test strategy and detailed prophylactic care education should be taken in patients with severe recurrent rhabdomyolysis, who are the high risk group of LPIN1 genetic defects.Keywords
Funding Information
- youth program of national natural science foundation of china (81400744)
This publication has 22 references indexed in Scilit:
- Rhabdomyolysis-Associated Mutations in Human LPIN1 Lead to Loss of Phosphatidic Acid Phosphohydrolase ActivityPublished by Springer Science and Business Media LLC ,2015
- Acute rhabdomyolysis and inflammationJournal of Inherited Metabolic Disease, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblastsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise‐induced myalgiaJournal of Inherited Metabolic Disease, 2012
- Fatal Rhabdomyolysis in 2 Children with LPIN1 MutationsThe Journal of Pediatrics, 2012
- LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhoodHuman Mutation, 2010
- Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in ChildhoodAmerican Journal of Human Genetics, 2008
- Evolutionary Genomics of the HAD Superfamily: Understanding the Structural Adaptations and Catalytic Diversity in a Superfamily of Phosphoesterases and Allied EnzymesJournal of Molecular Biology, 2006
- Proinflammatory cytokines and skeletal muscleCurrent Opinion in Clinical Nutrition and Metabolic Care, 2004